Clinical Trial

Biomarker Analysis Data From a Randomized Phase II Study in Patients With Nasopharyngeal Carcinoma Treated With Chemotherapy and Radiotherapy

Completed
View on ClinicalTrials.gov →
Summary
Clinicopathological and genomic data (Next generation sequencing and IHC/CISH) in available tissues were performed in patients with nasopharyngeal carcinoma who participated in a previously conducted randomized phase II study that evaulated induction chemotherapy followed by CCRT with CCRT alone.
Trial Details
NCT Number NCT07741110
Lead Sponsor Hellenic Cooperative Oncology Group
Conditions Nasopharyngeal Carcinoma (NPC)
Enrollment 141 participants
Start Date 2003-10-01
Primary Completion 2008-02-28 (estimated)
Study Completion 2008-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-08-03